Cargando…
Mapping the landscape of synthetic lethal interactions in liver cancer
Almost all the current therapies against liver cancer are based on the “one size fits all” principle and offer only limited survival benefit. Fortunately, synthetic lethality (SL) may provide an alternate route towards individualized therapy in liver cancer. The concept that simultaneous losses of t...
Autores principales: | Yang, Chen, Guo, Yuchen, Qian, Ruolan, Huang, Yiwen, Zhang, Linmeng, Wang, Jun, Huang, Xiaowen, Liu, Zhicheng, Qin, Wenxin, Wang, Cun, Chen, Huimin, Ma, Xuhui, Zhang, Dayong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419043/ https://www.ncbi.nlm.nih.gov/pubmed/34522226 http://dx.doi.org/10.7150/thno.63416 |
Ejemplares similares
-
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer
por: Yang, Chen, et al.
Publicado: (2022) -
Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma
por: Liu, Zhicheng, et al.
Publicado: (2022) -
Multi-region sequencing with spatial information enables accurate heterogeneity estimation and risk stratification in liver cancer
por: Yang, Chen, et al.
Publicado: (2022) -
The tumor therapy landscape of synthetic lethality
por: Zhang, Biyu, et al.
Publicado: (2021) -
Integrative analysis of CRISPR screening data uncovers new opportunities for optimizing cancer immunotherapy
por: Li, Yan, et al.
Publicado: (2022)